Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
954.49
-24.18 (-2.47%)
At close: Jun 19, 2026
Market Cap93.44B +1.6%
Revenue (ttm)75.76B +9.0%
Net Income8.31B +56.3%
EPS84.85 +56.3%
Shares Out 97.90M
PE Ratio11.25
Forward PE8.12
Dividend40.00 (4.19%)
Ex-Dividend DateApr 22, 2026
Volume24,286
Open952.20
Previous Close978.67
Day's Range948.50 - 988.98
52-Week Range821.00 - 1,304.00
Beta0.17
AnalystsStrong Buy
Price Target1,300.00 (+36.2%)
Earnings DateAug 28, 2026

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; and import and marketing of nutritional products. It also imports and markets diagnostic equipment, m... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1888
Employees 1,380
Stock Exchange Pakistan Stock Exchange
Ticker Symbol ABOT
Full Company Profile

Financial Performance

In 2025, PSX:ABOT's revenue was 75.40 billion, an increase of 10.59% compared to the previous year's 68.18 billion. Earnings were 7.97 billion, an increase of 52.20%.

Financial Statements